Titre :
  • Everolimus plus exemestane in postmenopausal patients with HR+ breast cancer: BOLERO-2 final progression-free survival analysis
Auteur : Yardley, Denise ; Burris, Howard H.A. ; Noguchi, Shinzaburo S. ; Pritchard, Kathleen ; Baselga, José ; Gnant, Michael ; Hortobagyi, Gabriel N. ; Campone, Mario ; Pistilli, Barbara B. ; Piccart-Gebhart, Martine ; Melichar, Bohuslav B. ; Petrakova, Katarina K. ; Arena, Francis F.P. ; Erdkamp, Frans F. ; Harb, Wael W.A. ; Feng, Wentao W. ; Cahana, Ayelet A. ; Taran, Tetiana T. ; Lebwohl, David ; Rugo, Hope
Informations sur la publication : Advances in therapy, 30, 10, (page 870-884)
Statut de publication : Publié, 2013-10
Sujet CREF : Sciences bio-médicales et agricoles
Pharmacologie
Mots-clés : Advanced breast cancer
Everolimus
Exemestane
Hormone receptor positive
Nonsteroidal aromatase inhibitors
Oncology
Postmenopausal
Progression-free survival
Mots-clés MeSH : Adult
Aged
Aged, 80 and over
Androstadienes -- administration & dosage
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Bone Neoplasms -- drug therapy -- secondary
Breast Neoplasms -- drug therapy -- metabolism -- pathology
Disease-Free Survival
Double-Blind Method
Female
Humans
Liver Neoplasms -- drug therapy -- secondary
Lung Neoplasms -- drug therapy -- secondary
Middle Aged
Postmenopause
Receptors, Estrogen -- metabolism
Receptors, Progesterone -- metabolism
Sirolimus -- administration & dosage -- analogs & derivatives
Treatment Outcome
Note : SCOPUS: ar.j
Langue :
  • Anglais
Identificateurs : urn:issn:0741-238X 
info:doi/10.1007/s12325-013-0060-1
info:pmid/24158787